Small Caps Small Caps

QMines (ASX: QML) chairman Andrew Sparke joins Small Caps to discuss the company's receipt of positive news from a pre-feasibility study (PFS) of its proposed development of the Mt Chalmers copper and gold mine in Queensland.

The Mt Chalmers study demonstrated that the project is a technically and financially robust and supports a stand-alone 1 million tonnes per annum process plan.

A significant milestone for QMines, the PFS result demonstrates Mt Chalmers is a

project with scale and potential for development.

The study also confirmed significant growth options within the Sulphide City, Scorpion and Woods Shaft deposits not currently in the mine plan.

Importantly, studies confirmed Mt Chalmers can be commercialised using industry standard treatment processes and techniques, providing low-cost development options at a time when gold and copper prices are surging.

Article:https://smallcaps.com.au/qmines-study-viable-future-mt-chalmers-copper-gold-deposit/

For more information on QMines:https://smallcaps.com.au/stocks/asx-qml/
See omnystudio.com/listener for privacy information.

International Graphite (ASX: IG6) managing director and chief executive officer Andrew Worland joins Small Caps to discuss the recent receipt of a $6.5 million grant from the Western Australian government.

The new grant takes the company’s total funding from the State’s Collie Just Transition Program to $8.5 million.

As well as the WA government support, International Graphite received $4.7 million in Federal funding as part of the Critical Minerals Development Program to support its mine-to-market graphite supply chain plans in WA.

The latest show of government support for the innovative battery materials developer will help advance the company's plans for a 4,000 tonnes per annum commercial-scale graphite micronising operation, at Collie, south of Perth.

The award is just the latest development this year in International Graphite's mine-to-market battery anode plans processing of graphite concentrate feed at Collie from its Springdale Graphite Project in WA’s south-east.

Earlier this year International Graphite received $1.3 million from the Australian Research and Development Tax Incentive Scheme for the 2023 financial year and raised $3 million in a placement, while the company will wrap up a $1 million SPP in the near future.

Articles:https://smallcaps.com.au/international-graphite-capital-raising-advance-springdale-graphite-project/https://smallcaps.com.au/international-graphite-secures-wa-funding-first-downstream-processing-plant/

For more information on International Graphite:https://smallcaps.com.au/stocks/asx-ig6/
See omnystudio.com/listener for privacy information.

RocketBoots (ASX: ROC) chief executive officer Joel Rappolt joins Small Caps to discuss how the company's cutting-edge AI and machine learning technologies are reshaping profitability and customer service in the retail and banking sectors

RocketBoots leverages AI to optimise workforce planning and prevent loss, dramatically improving customer experiences and net promoter scores.

Joel shares insights into RocketBoots’ journey from their successful IPO to deploying transformative AI technologies in markets across the UK, EU and USA.

For more information on RocketBoots:https://smallcaps.com.au/stocks/asx-roc/
See omnystudio.com/listener for privacy information.

Gerald Celente, founder of the Trends Research Institute and Trends Journal magazine, joins Small Caps to discuss the current events that are forming future trends.

With a 40-year track record of identifying, tracking and forecasting trends, Gerald is renowned as the world's #1 trend forecaster.

Topics discussed include: WW3, gold and silver, the office building bust and banks, the levels of debt, AI and much more..
See omnystudio.com/listener for privacy information.

Anatara Lifesciences (ASX: ANR) executive chair Dr David Brookes joins Small Caps to discuss the progress of the company's trial of a potential treatment for the aptly named irritable bowel syndrome (IBS).

The company recently received the go-ahead to enrol patients for the second stage of its pivotal GaRP-IBS trial, which is to be conducted at 5 sites in Melbourne, Sydney and Brisbane.

Anatara has received highly encouraging findings from Stage 1 of the GaRP-IBS clinical trial and Stage 2 of the trial will progress these promising developments to further efficacy claims .

Under the trial guidelines, participants will be randomly placed into two groups to take either the optimum dose of the GaRP product selected from Stage 1 or the placebo.

It is expected that each patient will take approximately three months to complete the trial, which involves a wash-out period and then 8 weeks on the product or placebo.

While IBS is a fairly common issue, with an estimated 5% to 10% of the world's population currently be suffering from the syndrome, many of those people may well be unaware of what the issue is.

April is annual IBS Awareness Month with the aim this year to help destigmatise the different types of syndrome people may be suffering.

Approximately 1 in 5 Australians experience the unpleasant symptoms of irritable bowel syndrome (IBS) at some time.

Articles:https://smallcaps.com.au/anatara-lifesciences-garp-therapy-trial-extension-treat-irritable-bowel-syndrome/https://smallcaps.com.au/ibs-awareness-month-anatara-lifesciences-trial-offers-hope-millions/

For more information on Anatara Lifesciences:https://smallcaps.com.au/stocks/asx-anr/
See omnystudio.com/listener for privacy information.

Barry Dawes, executive chairman at Martin Place Securities, join Small Caps to share his views on the recent rise in gold and silver prices.

Other topics discussed include various commodities such as copper, iron ore and uranium.Discussion on currencies such as the US dollar, Japanese yen and Australian dollar.And some ASX stocks.

To find out about investment opportunities in IPOs and placements visit Cap Raise:https://capraise.com/

-----------------------

Small Caps is Australia's #1 site for market news & information on ASX listed small cap companies.

-----------------------

WEBSITEhttps://smallcaps.com.au/

PODCASThttps://smallcaps.com.au/podcast/

SOCIAL MEDIAFacebook: https://www.facebook.com/SmallCapsASXTwitter: https://twitter.com/SmallCapsASXLinkedIn: https://www.linkedin.com/company/small-caps/

NEWSLETTERhttps://smallcaps.com.au/subscribe/
See omnystudio.com/listener for privacy information.